CG Oncology, Inc. Common stock (CGON) Investor Relations Documents

CG Oncology, Inc. Common stock (CGON) investor relations documents from the company's IR site: 10 presentations, 30 press releases; latest deck 2026-05-16. Read in-app with summaries. First-party data.

https://cgoncology.com/wp-content/uploads/2026/05/First_Results_from_CORE-008_Cohort_CX.pdf — Phase 2 CORE-008 Cohort CX results show cretostimogene plus gemcitabine is safe and effective for high-risk BCG-exposed or BCG-unresponsive NMIBC.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06Press releaseCG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
2026-07-27Press releaseCG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
2026-05-28Press releaseCG Oncology to Present at Upcoming Investor Conferences in June
2026-05-28Press releasepost
2026-05-19Press releaseSUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Resear
2026-05-16Presentationhttps://cgoncology.com/wp-content/uploads/2026/05/First_Results_from_CORE-008_Cohort_CX.pdf
2026-05-15Press releaseCG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination The
2026-05-15Press releasepost
2026-05-15Press releasepost
2026-05-15Press releasepost
2026-05-11Press releaseCG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIB
2026-05-08Press releaseCG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
2026-05-08Press releaseCG Oncology Reports…
2026-05-05Press releaseCG Oncology to Present at Upcoming Investor Conferences in May
2026-05-05Press releaseCG Oncology to Present…
2026-03-18Presentationhttps://cgoncology.com/wp-content/uploads/2026/03/Narayan_SESAUA-2026_Topline-Results-BOND-003-Cohort-P.pdf
2026-03-18Presentationhttps://cgoncology.com/wp-content/uploads/2026/03/Joshi_Encore-BOND-003-Cohort-C_SES-2026_Final.pdf
2026-03-18Presentationhttps://cgoncology.com/wp-content/uploads/2026/03/Joshi_SESAUA-2026_First-Results-CORE-008-Cohort-A_Final-CG-093.pdf
2026-03-16Presentationhttps://cgoncology.com/wp-content/uploads/2026/03/Bivalacqua_EAU-2026_CORE-008-Cohort-B-TIPS_Final-1.pdf
2026-03-02Presentationhttps://cgoncology.com/wp-content/uploads/2026/03/P0214_CORE-008-Cohort-A-TR_Trinity-Bivalacqua_Final-1.pdf
2026-02-27Press releaseCG Oncology Reports…
2026-02-27Press releasehttps://cgoncology.com/news-media/cg-oncology-reports-2025-year-end-financial-results-and-provides-business-updates
2026-02-27Press releaseCG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
2026-02-23Press releaseCG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
2026-02-23Press releaseCG Oncology to Present…
2026-01-09Press releaseCG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
2026-01-09Press releaseCG Oncology Provides…
2026-01-06Press releaseCG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
2026-01-06Press releaseCG Oncology to Present…
2025-12-18Press releaseSUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
2025-12-18Press releaseSUO-CTC and CG Oncology…
2025-12-05Presentationhttps://cgoncology.com/wp-content/uploads/2025/12/SUO_2025_First_Results_from_CORE-008_Cohort_A.pdf
2025-12-05Presentationhttps://cgoncology.com/wp-content/uploads/2025/12/SUO_2025_Topline_Results_from_BOND-003_Cohort_P_Podium.pdf
2025-12-05Press releaseNew Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle
2025-12-05Press releaseNew Cretostimogene…
2025-11-26Press releaseCG Oncology Announces New Board Member and Board Transition
2025-11-25Press releaseCG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual M
2025-11-25Press releaseCG Oncology to Present…
2025-11-20Presentationhttps://cgoncology.com/wp-content/uploads/2025/11/2021_sitc_core-001_poster-1.pdf
2025-11-20Presentationhttps://cgoncology.com/wp-content/uploads/2025/12/SUO_2025_Final_Results_BOND_003_Cohort_C_ePoster.pdf

CGON overview · CGON earnings · CGON financials · CGON KPIs · CGON ownership · CGON peers · CGON filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.